| Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2 [2-(-4-octylphenyl) ethyl] propane-1, 3-diol hydrochloride) in rats after oral and intravenous doses GML Meno-Tetang, H Li, S Mis, N Pyszczynski, P Heining, P Lowe, ... Drug Metabolism and Disposition 34 (9), 1480-1487, 2006 | 152 | 2006 |
| From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy M Colin, S Dujardin, S Schraen-Maschke, G Meno-Tetang, C Duyckaerts, ... Acta neuropathologica 139 (1), 3-25, 2020 | 149 | 2020 |
| On the prediction of the human response: a recycled mechanistic pharmacokinetic/pharmacodynamic approach GML Meno‐Tetang, PJ Lowe Basic & clinical pharmacology & toxicology 96 (3), 182-192, 2005 | 113 | 2005 |
| Efficacy of Epratuzumab, an Anti‐CD 22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY … JE Gottenberg, T Dörner, H Bootsma, V Devauchelle‐Pensec, ... Arthritis & Rheumatology 70 (5), 763-773, 2018 | 73 | 2018 |
| A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy R Rauck, CW Makumi, S Schwartz, O Graff, G Meno‐Tetang, CF Bell, ... Pain Practice 13 (6), 485-496, 2013 | 60 | 2013 |
| Physiologically based pharmacokinetic (PBPK) modeling of everolimus (RAD001) in rats involving non-linear tissue uptake R Laplanche, GML Meno-Tetang, R Kawai Journal of pharmacokinetics and pharmacodynamics 34, 373-400, 2007 | 60 | 2007 |
| Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial V Meininger, PF Pradat, A Corse, S Al-Sarraj, B Rix Brooks, JB Caress, ... PloS one 9 (5), e97803, 2014 | 59 | 2014 |
| A translational platform PBPK model for antibody disposition in the brain HY Chang, S Wu, G Meno-Tetang, DK Shah Journal of pharmacokinetics and pharmacodynamics 46, 319-338, 2019 | 54 | 2019 |
| Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models EA Chowdhury, G Meno-Tetang, HY Chang, S Wu, HW Huang, T Jamier, ... Advanced Drug Delivery Reviews 170, 214-237, 2021 | 48 | 2021 |
| Pharmacokinetics and cell trafficking dynamics of 2-amino-2-[2-(4-octylphenyl) ethyl] propane-1, 3-diol hydrochloride (FTY720) in cynomolgus monkeys after single oral and … H Li, GML Meno-Tetang, K Chiba, N Arima, P Heining, WJ Jusko Journal of Pharmacology and Experimental Therapeutics 301 (2), 519-526, 2002 | 38 | 2002 |
| Development of a physiologically based pharmacokinetic model for a domain antibody in mice using the two-pore theory A Sepp, A Berges, A Sanderson, G Meno-Tetang Journal of pharmacokinetics and pharmacodynamics 42, 97-109, 2015 | 31 | 2015 |
| Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats A Sepp, G Meno-Tetang, A Weber, A Sanderson, O Schon, A Berges Journal of pharmacokinetics and pharmacodynamics 46, 339-359, 2019 | 25 | 2019 |
| Hallmarks of neurodegenerative disease: A systems pharmacology perspective P Bloomingdale, T Karelina, V Ramakrishnan, S Bakshi, ... CPT: Pharmacometrics & Systems Pharmacology 11 (11), 1399-1429, 2022 | 20 | 2022 |
| Synergistic interaction between dehydroepiandrosterone and prednisolone in the inhibition of rat lymphocyte proliferation GML Meno-Tetang, YY Hon, WJ Jusko Immunopharmacology and immunotoxicology 18 (3), 443-456, 1996 | 12 | 1996 |
| Pharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat GML Meno-Tetang, YY Hon, S Van Wart, WJ Jusko Drug metabolism and drug interactions 15 (1), 51-70, 1999 | 7 | 1999 |
| Influence of gender on prednisolone effects on whole blood T‐cell deactivation and trafficking in rats GML Meno‐Tetang, JVS Gobburu, WJ Jusko Journal of pharmaceutical sciences 88 (1), 46-51, 1999 | 6 | 1999 |
| Assessment of AAV9 distribution and transduction in rats after administration through Intrastriatal, Intracisterna magna and Lumbar Intrathecal routes J Chandran, EA Chowdhury, M Perkinton, T Jamier, D Sutton, S Wu, ... Gene Therapy 30 (1), 132-141, 2023 | 4 | 2023 |
| Physiologically-based pharmacokinetic (PBPK) modelling of FTY720 in rats following oral and intravenous doses GML Meno-Tetang, H Li, S Mis, N Pyszczynski, P Heining, PJ Lowe, ... Drug Metabolism and Disposition, 2006 | 3 | 2006 |
| Insights into FTY720 use in transplantation from a human exposure-lymphocyte mechanistic model based on clinical data. JM Kovarik, H Schmidli, G Meno Tetang, A Slade, F Picard, ... AMERICAN JOURNAL OF TRANSPLANTATION 5, 190-190, 2005 | 2 | 2005 |
| Whole-Body Disposition and Physiologically Based Pharmacokinetic Modeling of Adeno-Associated Viruses and the Transgene Product S Liu, EA Chowdhury, V Xu, A Jerez, L Mahmood, BQ Ly, HK Le, ... Journal of Pharmaceutical Sciences 113 (1), 141-157, 2024 | 1 | 2024 |
